{
    "clinical_study": {
        "@rank": "20100", 
        "acronym": "IV", 
        "arm_group": {
            "arm_group_label": "sentinel arm", 
            "arm_group_type": "Experimental", 
            "description": "all patients will be recieving Iv therapy by using the sentinel controller, a device that is mounted on the IV administration set."
        }, 
        "brief_summary": {
            "textblock": "The study will evaluate the functionality of IMMAGES , an intravenous infusion device\n      system, in patients hospitalized in Bait Balev hospital.  The study will aim to determine\n      how the IMMAGES system integrates within IV infusion therapy regime   and what are the\n      advantages and disadvantages, if any, of using this system within the prescribed setting."
        }, 
        "brief_title": "Safety and Efficacy of Immages System in Patients Recieving IV Therapy", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sepsis", 
            "Bacteriemia", 
            "CHF"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteremia", 
                "Sepsis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Using the IMMAGES system in patients recieving IV therapy will provide the nursing teams\n      on-line information regarding the infusions and will allow them to monitor and manage the\n      treatments in real-time, providing better and safer care for the patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Inclusion criteria:\n\n               1. Patients requiring infusion therapy\n\n               2. Patients receiving  infusion therapy by gravity flow or by pump\n\n               3. patients are scheduled to receive at least once a day an infusion therapy\n\n               4. Patients are scheduled to receive an infusion therapy for at least 3 days\n\n               5. Adult over age of 18 years\n\n               6. Informed consent form signed by patient.\n\n                  Exclusion Criteria:\n\n               1. Informed consent form not signed\n\n               2. Patients are scheduled to receive less than once a day an infusion therapy\n\n               3. patients to receive less than 3 days of infusion therapy\n\n               4. patients not hospitalized in a ward that is participating in the study.\n\n               5. patients participating in another clinical study or clinical field test\n\n               6. Patients require isolation treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020811", 
            "org_study_id": "BBALEV-1"
        }, 
        "intervention": {
            "arm_group_label": "sentinel arm", 
            "intervention_name": "Sentinel", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "email": "gisele_s@bbalev.co.il", 
                "last_name": "Gisele Sasson, MD", 
                "phone": "972-52-4425581"
            }, 
            "facility": {
                "address": {
                    "city": "Bat Yam", 
                    "country": "Israel"
                }, 
                "name": "Bait Balev hospital"
            }, 
            "investigator": {
                "last_name": "Gisele Sasson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Study to Assess the Functionality of Pro-IV's IMMAGES Infusion System in Patients Hospitalized in Bait Balev, Receiving Intravenous Therapy", 
        "overall_contact": {
            "last_name": "Gizele Sasson, MD", 
            "phone": "972-52-4425581"
        }, 
        "overall_contact_backup": {
            "email": "michal@pro-iv.co.il", 
            "last_name": "michal Devir, MD", 
            "phone": "972-9-8664128"
        }, 
        "overall_official": {
            "affiliation": "PRo-IV", 
            "last_name": "michal devir, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Successful operation of IMMAGES defined by patient receiving the prescribed IV medication using the  IMMAGES system , openning of the controller valve including using the smartphone application and the management software", 
            "safety_issue": "Yes", 
            "time_frame": "as long as the patient is reciving the IV prescribed medication, and no longer than 10 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020811"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "If there is an error related to administration of wrong drug.  to the wrong patient , on the wrong timing - the valve of the controller will not open , and the IV line will stay closed, and the patient will not get the wrong drug.", 
            "measure": "- Detection of medical errors by IMMAGES", 
            "safety_issue": "Yes", 
            "time_frame": "up to 5 minutes from activating the controller on the IV line"
        }, 
        "source": "PRo-IV", 
        "sponsors": {
            "collaborator": {
                "agency": "Bait Balev Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "PRo-IV", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}